GOTHENBURG, SE / ACCESSWIRE / February 29, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) The Lancet reports[1] that for the first time in medical history, transportation of a donor heart...
XVIVO is a Sweden-based medical technology company that develops optimized solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation.